Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles

• Status: Completed
• Trial end date: 2010-12-13
• Target enrollment: 0
• Participant gender: Female

Summary

This study is examining a birth control patch for 13 cycles (1 year).

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bayer
• Treatments: Contraceptive Agents; Estradiol; Ethinyl Estradiol; Gestodene

Criteria

Inclusion Criteria:

• Requiring contraception

• Normal cervical smear

• Maximum age for smokers is 35

• History of regular cyclic menstrual periods

Exclusion Criteria:

• Pregnancy or lactation

• Significant skin reaction to transdermal preparations or sensitivity to surgical / medical tape

• Any disease that may worsen under hormonal treatment (cardiovascular, liver, metabolic)

• Use of other contraceptive methods than study medication